ANTITHROMBIC THERAPY IN THE PRIMARY PREVENTION OF STROKE

ANTITHROMBIC THERAPY IN THE PRIMARY PREVENTION OF STROKE

The author reviews the meta-analyses of recent large studies of the primary prevention of stroke with antithrombotic drugs. It is stated that acetylsalicylic acid and clopidogrel are antithrombotic agents of proven clinical efficacy in patients with stroke risk factors (coronary heart disease, clini...

Full description

Bibliographic Details
Main Author:	I. S. Yavelov
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2009-03-01
Series:	Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:	stroke antithrombotic therapy acetylsalicylic acid clopidogrel
Online Access:	https://nnp.ima-press.net/nnp/article/view/5

Similar Items

ACETYLCALICYLIC ACID AND PREVENTION OF STROKE IN HIGH-RISK GROUP PATIENTS
by: I. S. Yavelov
Published: (2009-12-01)

Antithrombotic Therapy in Patients with Coronary Artery Disease and Prior Stroke
by: Elisa Bellettini, et al.
Published: (2021-04-01)

Role of clopidogrel role in secondary prevention of ischemic stroke
by: K. S. Meshkova, et al.
Published: (2014-12-01)

Prevention of stroke: Antihypertensives, cholesterol-lowering drugs, antithrombotics, anticoagulation, carotid surgery, and stenting
by: Michael Brainin
Published: (2018-01-01)

Monocyte Chemotactic Protein-1 as a Potential Biomarker for Early Anti-Thrombotic Therapy after Ischemic Stroke
by: Karin Weissenborn, et al.
Published: (2012-07-01)

THE SELECTION PROBLEMS OF ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION WITH COMORBIDITIES
by: N. A. Koziolova, et al.
Published: (2015-08-01)

ANTITHROMBOCYTIC THERAPY IN THE SECONDARY PREVENTION OF ISCHEMIC STROKE
by: A. V. Fonyakin, et al.
Published: (2009-12-01)

ANTITHROMBOTIC THERAPY IN THE PREVENTION OF RECURRENT ISCHEMIC STROKE
by: A. V. Fonyakin
Published: (2009-06-01)

FEATURES OF PLATELET HEMOSTASIS IN PATIENTS WITH VARIOUS SENSITIVITY TO ANTIPLATELET THERAPY IN STABLE ANGINA PECTORIS AFTER PLANNED PERCUTANEOUS CORONARY INTERVENTION
by: Pronko T. P., et al.
Published: (2017-12-01)

Acetylsalicylic acid in the prevention and treatment of ischemic stroke
by: A. V. Fonyakin
Published: (2010-06-01)

Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults – a systematic review
by: Maren Meinshausen, et al.
Published: (2017-10-01)

High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice
by: N. F. Puchinyan, et al.
Published: (2016-09-01)

OPINION SURVEY OF THE CARDIOLOGISTS IN BULGARIA REGARDING THERAPY WITH ACETYLSALICYLIC ACID, CLOPIDOGREL AND ACENOCOUMAROL IN PATIENTS UNDERGOING DENTAL EXTRACTIONS
by: Atanaska Dinkova, et al.
Published: (2017-10-01)

Ischemic stroke and antithrombotic therapy: key aspects
by: M. Yu. Maksimova, et al.
Published: (2019-12-01)

RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: D. H. Aynetdinova, et al.
Published: (2015-12-01)

Short-Term Clinical Outcomes of Single Versus Dual Antiplatelet Therapy after Infrainguinal Endovascular Treatment for Peripheral Arterial Disease
by: Jetty Ipema, et al.
Published: (2020-10-01)

Atherothrombotic stroke in non-valvular atrial fibrillation
by: I. S. Yavelov, et al.
Published: (2019-06-01)

Clopidogrel as a part of double disaggregant therapy in ACS: a reasonable choice in complex clinical situations
by: V. V. Kashtalap, et al.
Published: (2019-04-01)

ACTUAL PROBLEMS OF ANTITOMBOTIC THERAPY IN ACUTE CORONARY SYNDROME (FOLLOWING THE MATERIAL PRESENTED AT THE EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2017)
by: V. V. Kashtalap, et al.
Published: (2017-11-01)

Small bowel injuries due to nonsteroidal anti-inflammatory drugs and antiplatelet therapy. Approaches to prevention and treatment
by: O M Drapkina, et al.
Published: (2016-12-01)

OPINION SURVEY OF THE GENERAL PRACTITIONERS IN BULGARIA REGARDING THERAPY WITH ACETYLSALICYLIC ACID, CLOPIDOGREL AND ACENOCOUMAROL IN PATIENTS UNDERGOING DENTAL EXTRACTIONS
by: Atanaska Dinkova, et al.
Published: (2017-11-01)

Antiplatelet drug resistance in patients with coronary heart disease
by: V. A. Sulimov, et al.
Published: (2012-12-01)

The safety of upper gastrointestinal endoscopic biopsy in patients receiving antithrombic drugs. A single-centre prospective observational study
by: Hilmi Bozkurt, et al.
Published: (2019-10-01)

The quality of prior antithrombotic therapy and the severity of ischemic stroke in atrial fibrillation
by: L. A. Geraskina, et al.
Published: (2020-10-01)

A Rational Approach to a De-Escalation of Double Antithrombotic Therapy: The Possibilities of Clopidogrel
by: V. V. Kashtalap, et al.
Published: (2019-10-01)

Thrombosis prevention in percutaneous coronary interventions
by: V. P. Lupanov, et al.
Published: (2009-08-01)

Antitumor effects of cardiovascular drugs
by: I. I. Shaposhnik, et al.
Published: (2020-10-01)

INDIVIDUAL ANTIPLATELET THERAPY IN PATIENTS WITH ATHEROSCLEROSIS OF LOWER EXTREMITIES: MYTH OR REALITY?
by: O. V. Sirotkina, et al.
Published: (2018-01-01)

EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: A. L. Alyavi, et al.
Published: (2016-01-01)

THE EFFECTIVENESS OF CLOPIDOGREL AS AN ANTITHROMBOTIC COMPARED TO TICLOPIDINE AND ASPIRIN (META-ANALYSIS)
by: Titien Siwi Hartayu, et al.
Published: (2017-05-01)

Patient-specific choice of an antiplatelet drug for long-term therapy of coronary heart disease: rationale and implementationL
by: NA Mazur
Published: (2014-12-01)

WARFARIN IN PATIENTS WITH CARDIOEMBOLIC STROKE
by: E. N. Dankovtseva, et al.
Published: (2015-12-01)

Experimental study of systemic hemostatic effects of fibrin monomer in inhibition of platelet aggregation function
by: V. M. Vdovin, et al.
Published: (2020-04-01)

Antiplatelet therapy in secondary prevention of ischemic stroke
by: V. A. Parfyonov, et al.
Published: (2015-12-01)

THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE
by: P. R. Kamchatnov, et al.
Published: (2014-07-01)

THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE
by: P. R. Kamchatnov, et al.
Published: (2014-07-01)

ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
by: D. H. Ainetdinova, et al.
Published: (2016-01-01)

RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS
by: A. A. Lomonosova, et al.
Published: (2015-12-01)

Treatment of Patients with Stable Manifestations of Atherosclerosis: New Opportunities
by: article Editorial
Published: (2019-07-01)

Use of Oral Anticoagulation and Diabetes Do Not Inhibit the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes
by: Philipp Moog, et al.
Published: (2020-08-01)